Bionics Institute, East Melbourne, Victoria, Australia.
Department of Neurosurgery, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
PLoS One. 2021 Jul 15;16(7):e0254504. doi: 10.1371/journal.pone.0254504. eCollection 2021.
The efficacy of subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD) depends on how closely electrodes are implanted relative to an individual's ideal stimulation location. Yet, previous studies have assessed how closely electrodes are implanted relative to the planned location, after homogenizing data to a reference. Thus here, we measured how accurately electrodes are implanted relative to an ideal, dorsal STN stimulation location, assessed on each individual's native imaging. This measure captures not only the technical error of stereotactic implantation but also constraints imposed by planning a suitable trajectory.
This cross-sectional study assessed 226 electrodes in 113 consecutive PD patients implanted with bilateral STN-DBS by experienced clinicians utilizing awake, microelectrode guided, surgery. The error (Euclidean distance) between the actual electrode trajectory versus a nominated ideal, dorsal STN stimulation location was determined in each hemisphere on native imaging and predictive factors sought.
The median electrode location error was 1.62 mm (IQR = 1.23 mm). This error exceeded 3 mm in 28/226 electrodes (12.4%). Location error did not differ between hemispheres implanted first or second, suggesting brain shift was minimised. Location error did not differ between electrodes positioned with (48/226), or without, a preceding microelectrode trajectory shift (suggesting such shifts were beneficial). There was no relationship between location error and case order, arguing against a learning effect.
DISCUSSION/CONCLUSION: The proximity of STN-DBS electrodes to a nominated ideal, dorsal STN, stimulation location is highly variable, even when implanted by experienced clinicians with brain shift minimized, and without evidence of a learning effect. Using this measure, we found that assessments on awake patients (microelectrode recordings and clinical examination) likely yielded beneficial intraoperative decisions to improve positioning. In many patients the error is likely to have reduced therapeutic efficacy. More accurate methods to implant STN-DBS electrodes relative to the ideal stimulation location are needed.
丘脑底核(STN)深部脑刺激(DBS)在帕金森病(PD)中的疗效取决于电极相对于个体理想刺激位置的植入精度。然而,之前的研究都是在将数据均质化为参考标准后,评估电极相对于计划位置的植入精度。因此,在这里,我们在每个患者的原始影像上测量了电极相对于理想的背侧 STN 刺激位置的植入精度。该测量不仅捕捉到了立体定向植入的技术误差,还捕捉到了规划合适轨迹所带来的限制。
这项横断面研究评估了 113 名连续 PD 患者在经验丰富的临床医生在清醒、微电极引导下进行的双侧 STN-DBS 手术中植入的 226 个电极。在每个半球的原始影像上确定了实际电极轨迹与指定的理想背侧 STN 刺激位置之间的误差(欧几里得距离),并寻找了预测因素。
电极位置误差的中位数为 1.62mm(IQR=1.23mm)。28/226 个电极(12.4%)的位置误差超过 3mm。首先植入或其次植入的半球之间的位置误差没有差异,这表明脑移位被最小化。位置误差与是否有前置微电极轨迹移位的电极(48/226)无关(这表明这种移位是有益的)。位置误差与病例顺序之间没有关系,这表明不存在学习效应。
讨论/结论:即使在脑移位最小化且没有学习效应的情况下,由经验丰富的临床医生植入,STN-DBS 电极与指定的理想背侧 STN 刺激位置的接近程度也高度可变。使用该测量方法,我们发现对清醒患者(微电极记录和临床检查)的评估可能会产生有益的术中决策,以改善定位。在许多患者中,这种误差可能会降低治疗效果。需要更准确的方法来将 STN-DBS 电极相对于理想的刺激位置进行植入。